CPHI [CHINA PHARMA] 8-K: Item 8.01. Other Events. Dated: December 28, 2016
[Item 8.01. Other Events. Dated: December 28, 2016 CHINA PHARMA HOLDINGS, INC. 8-K 1 cphi8k122716.htm]
CPHI [CHINA PHARMA] 8-K: (Original Filing)
[Item 8.01. Other Events. Dated: December 28, 2016 CHINA PHARMA HOLDINGS, INC. 8-K 1 cphi8k122716.htm]
CPHI [CHINA PHARMA] 8-K: (Original Filing)
[Item 5.07 Submission of Matters to a Vote of Security Holders. On December 8, 2016, China Pharma Holdings, Inc. (the "Company") held its annual shareholders meeting for the fiscal year ended December 31, 2015 (the "Annual Meeting"). Holders of 27,271,585 shares of the Company's common stock were pre]
CPHI [CHINA PHARMA] 8-K: Item 5.07 Submission of Matters to a Vote
[Item 5.07 Submission of Matters to a Vote of Security Holders. On December 8, 2016, China Pharma Holdings, Inc. (the "Company") held its annual shareholders meeting for the fiscal year ended December 31, 2015 (the "Annual Meeting"). Holders of 27,271,585 shares of the Company's common stock were pre]
CPHI [CHINA PHARMA] 8-K: (Original Filing)
[] [Item 4.01. Effective November 28, 2016, Arshak Davtyan, Inc. (the "Former Accountant") resigned as the independent registered public accounting firm of China Pharma Holdings, Inc., a Nevada corporation (the "Company"). The resignation is primarily a result of the business adjustment of the Former]
CPHI [CHINA PHARMA] 8-K:
[] [Item 4.01. Effective November 28, 2016, Arshak Davtyan, Inc. (the "Former Accountant") resigned as the independent registered public accounting firm of China Pharma Holdings, Inc., a Nevada corporation (the "Company"). The resignation is primarily a result of the business adjustment of the Former]
CPHI [CHINA PHARMA] 10-Q: (Original Filing)
[☐ ☒ APPLICABLE ONLY TO CORPORATE ISSUERS: 2 CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES TABLE OF CONTENTS Page PART I FINANCIAL INFORMATION 4 Item 1.] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings]
CPHI [CHINA PHARMA] 10-Q: ☐ ☒ APPLICABLE ONLY TO CORPORATE ISSUERS: 2
[☐ ☒ APPLICABLE ONLY TO CORPORATE ISSUERS: 2 CHINA PHARMA HOLDINGS, INC. AND SUBSIDIARIES TABLE OF CONTENTS Page PART I FINANCIAL INFORMATION 4 Item 1.] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings]
